Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of LENZ Therapeutics Inc (NASDAQ: LENZ) was $32.30 for the day, up 3.19% from the previous closing price of $31.30. In other words, the price has increased by $3.19 from its previous closing price. On the day, 0.14 million shares were traded. LENZ stock price reached its highest trading level at $31.96 during the session, while it also had its lowest trading level at $30.735.
Ratios:
Our analysis of LENZ’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 28.63 and its Current Ratio is at 28.63. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Raymond James on September 27, 2024, initiated with a Outperform rating and assigned the stock a target price of $37.
On August 12, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $38.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 14 ’24 when Chevallard Daniel R. bought 3,188 shares for $15.68 per share. The transaction valued at 49,988 led to the insider holds 3,188 shares of the business.
MCCOLLUM JAMES W bought 31,332 shares of LENZ for $501,093 on May 13 ’24. The Director now owns 525,565 shares after completing the transaction at $15.99 per share. On Mar 21 ’24, another insider, RA CAPITAL MANAGEMENT, L.P., who serves as the Director of the company, bought 998,009 shares for $15.03 each. As a result, the insider paid 15,000,075 and bolstered with 3,319,339 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LENZ now has a Market Capitalization of 866278336 and an Enterprise Value of 681825088.
Stock Price History:
Over the past 52 weeks, LENZ has reached a high of $38.93, while it has fallen to a 52-week low of $11.31. The 50-Day Moving Average of the stock is 1.70%, while the 200-Day Moving Average is calculated to be 41.40%.
Shares Statistics:
LENZ traded an average of 163.23K shares per day over the past three months and 210110 shares per day over the past ten days. A total of 27.48M shares are outstanding, with a floating share count of 22.36M. Insiders hold about 18.69% of the company’s shares, while institutions hold 71.97% stake in the company. Shares short for LENZ as of 1732838400 were 2265687 with a Short Ratio of 13.88, compared to 1730332800 on 2069951.
